HONGCHANG INTERNATIONAL CO., LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2226 USD | -.--% |
|
-.--% | -36.18% |
| 04-01 | Hongchang International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 04-01 | Hongchang International Co., Ltd Announces Board Changes | CI |
| Sales 2022 | - | Sales 2023 | 2.68 214.2 | Capitalization | 181M 14.49B |
|---|---|---|---|---|---|
| Net income 2022 | -1M -80.05M | Net income 2023 | - 0 | EV / Sales 2022 * | - |
| Net Debt 2022 | 43.77M 3.5B | Net cash position 2023 | 896K 71.71M | EV / Sales 2023 | 67,297,029 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
-415
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 2.37% |
More Fundamentals
* Assessed data
More news
More press releases
| 3 months | -16.54% | ||
| 6 months | -55.48% | ||
| Current year | -36.18% |
Current year
0.20
0.40
1 year
0.200.75
3 years
0.200.75
5 years
0.200.75
10 years
0.200.75
| Managers | Title | Age | Since |
|---|---|---|---|
Zeng Qiang Lin
CEO | Chief Executive Officer | 28 | 16/02/23 |
Wendy Li
DFI | Director of Finance/CFO | 39 | 17/04/18 |
Siong Ang Ban
CHM | Chairman | 49 | 17/04/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Siong Ang Ban
CHM | Chairman | 49 | 17/04/18 |
Jian Xin Gao
BRD | Director/Board Member | 62 | 20/08/23 |
Zeng Qiang Lin
CEO | Chief Executive Officer | 28 | 16/02/23 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | - | +-NaN% | 30 |
| 22/04/24 | - | +-NaN% | 1 |
| 19/04/24 | - | +-NaN% | 10 |
| 17/04/24 | - | +-NaN% | 1 |
Delayed Quote OTC Markets, March 08, 2024 at 02:30 pm
More quotes
Hongchang International Co Ltd, formerly Heyu Biological Technology Corp, is a holding company mainly engaged in research and development and manufacture a medical product, the Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber (the Chamber). Utilizing submillimeter waves, the Chamber is a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -36.18% | 115M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- HCIL Stock
